United Therapeutics traded at $238.95 this Friday June 24th, decreasing $1.91 or 0.79 percent since the previous trading session. Looking back, over the last four weeks, United Therapeutics lost 4.62 percent. Over the last 12 months, its price rose by 32.75 percent. Looking ahead, we forecast United Therapeutics to be priced at 232.52 by the end of this quarter and at 214.26 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
238.95
Daily Change
-0.79%
Yearly
32.75%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Amarin 1.92 -0.07 -3.52% -58.44%
Ardelyx 0.59 -0.01 -1.30% -92.67%
Baxter International 66.78 1.70 2.61% -18.75%
Bayer 57.79 -0.75 -1.28% 11.59%
BioCryst Pharmaceuticals 10.76 0.59 5.80% -37.19%
Biogen 211.93 0.55 0.26% -39.09%
BioMarin Pharmaceutical 86.85 2.30 2.72% 2.43%
Emergent BioSolutions 32.76 0.42 1.30% -48.30%
Esperion Therapeutics 6.47 0.18 2.86% -72.68%
Gilead Sciences 63.08 0.50 0.80% -7.07%
GlaxoSmithKline 1,756.20 36.60 2.13% 24.27%
Halozyme Therapeutics 46.90 0.10 0.21% 3.90%
Intercept Pharmaceuticals 13.56 0.03 0.22% -38.53%
Insmed 21.42 1.57 7.91% -25.98%
Ionis Pharmaceuticals 39.25 0.23 0.59% 0.82%
Intra Cellular Therapies 55.62 -1.57 -2.75% 34.02%
J&J 182.29 2.63 1.46% 11.01%
Lexicon Pharmaceuticals 2.03 0.04 2.01% -64.51%
Moderna Inc 144.27 1.01 0.71% -34.40%
Omeros 2.61 -0.04 -1.32% -83.28%
Pfizer 51.59 1.50 2.99% 32.35%
PTC Therapeutics 40.22 0.11 0.27% -8.30%
Regeneron Pharmaceuticals 612.49 5.10 0.84% 11.25%
Seattle Genetics 179.33 5.33 3.06% 14.09%
Sangamo BioSciences 4.31 -0.06 -1.37% -64.14%
Sarepta Therapeutics 75.22 3.40 4.73% -6.44%
Teva Pharmaceutical Industries Ltd 2,677.00 18.00 0.68% -20.07%
United Therapeutics 238.95 -1.91 -0.79% 32.75%
Vertex Pharmaceuticals 292.55 9.05 3.19% 50.54%

Indexes Price Day Year
USND 11608 375.43 3.34% -19.17%
US400 2334 80.04 3.55% -14.38%

United Therapeutics
United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The Company market and sell four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH): Remodulin (treprostinil) Injection; Tyvaso (treprostinil) Inhalation Solution, which includes the Tyvaso Inhalation System; Orenitram (treprostinil) Extended-Release Tablets; and Adcirca (tadalafil) Tablets. In the United States, the Company also markets and sells an oncology product, Unituxin (dinutuximab) Injection, which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin. The Company is also engaged in early-stage research and development of a number of organ transplantation-related technologies, including regenerative medicine, xenotransplantation, and ex-vivo lung perfusion.